Detoxification treatments for opiate dependent adolescents

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 4, 2014, Pages

  Minozzi, Silvia ^a   Amato, Laura ^a   Bellisario, Cristina ^b   Davoli, Marina ^a  

^a DEPARTMENT OF EPIDEMIOLOGY   (Italy)

^b CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; CANNABIS; CLONIDINE; COCAINE; OPIATE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONIST;

ADOLESCENT; ALCOHOLISM; CANNABIS ADDICTION; COCAINE DEPENDENCE; DRUG DETOXIFICATION; FOLLOW UP; HEADACHE; HEALTH STATUS; HUMAN; META ANALYSIS; OPIATE ADDICTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW; SELF REPORT; SOCIAL STATUS; SYSTEMATIC REVIEW; MAINTENANCE CHEMOTHERAPY; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT DROPOUTS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA;

ADOLESCENT; BUPRENORPHINE; CLONIDINE; HUMANS; MAINTENANCE CHEMOTHERAPY; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT DROPOUTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84942756230     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006749.pub3     Document Type: Review

References (48)

1. Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, et al.Comparison of pharmacological treatments for opioid-dependent adolescents. Archives of General Psychiatry 2005;62(10):1157-64.
2. Woody GE. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial (Errata corrige). JAMA 2009;301(8):830.
3. Woody GE. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial (Errata corrige). JAMA 2013;319(14):1461.
4. Woody GE, Poole SA, Subramaniam G, Dugosh K, Bogenschutz M, Abbott P, et al.Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth. JAMA 2008;300(17):2003-11.
5. Baer JS, Garret SB, BeadnellB, Wells EA, Peterson PL. Brief motivational intervention with homeless adolescents: evaluating effects on substance use and service utilization. Psychology of Addictive Behaviors 2007;21(4):582-6.
6. Chakrabarti A, Woody GE, Griffin ML, Subramaniam G, Weiss RD. Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study. Drug and Alcohol Dependence 2010;107(2-3):253-6.
7. Ebner R, Zierer C, Schreiber W. After detoxification is before detoxification? Long term outcome of drug dependent adolescent [Nach dem Entzug=vor demEntzug? Langzeitvrlauf bei drogenabhangigen Jugendlichen]. Psychiatrische Praxis 2007;34(Suppl 1):s42-3.
8. Fiellin DA. Treatment of adolescent opioid dependence: no quick fix. JAMA 2008;300(17):2057-9.
9. Forcehimes AA, Bogenschutz MP, Tonigan JS, Woody GE. Impacy of therapeutic alliance on treatment outcome in opioid dependent adolescent and young adult treated with buprenorphine. Proceedings of the70th Annual Scientific Meeting of the College on Problems of Drug Dependence. 2008.
10. Godley SH, Dennis ML, Godely MD, Funk RR. Thirty-months relapse trajectory cluster groups among adolescents discharged from out-patients treatment. Addiction 2004;99(Suppl 2):129-39.
11. Hill KP, Bennett HE, Griffin ML, Connery HS, Fitzmaurice GM, Subramaniam G, et al.Association of cannabis use with opioid outcomes among opioid-dependent youth. Drug and Alcohol Dependence 2013;132(1-2):342-5.
12. Kemp R, Harris A, Vurel E, Siharthan T. Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry 2007;15(6):490-3.
13. Lehmann WX. The use of 1-alpha-acetyl-methadol (LAAM) as compared to methadone in the maintenance and detoxification of young heroin addicts. NIDA monograph 1973;8:82-3.
14. Lloyd RA, Katon RN, DuPont RL. Evolution of a treatment approach for young heroin addicts. Comparison of three treatment modalities. International Journal of Addiction 1974;9(2):229-39.
15. Mannelli P, Peindl K, Patkar AA, Wu LT, Tharwani HM, Gorelick D A. Problem drinking and low-dose naltrexone-assisted opioid detoxification.. Journal of Studies on Alcohol and Drugs 2011;72(3):507-13.
16. Moore SK, Marsch LA, Badger GJ, Solhkhah R, Hofstein Y. Improvement in psychopathology among opioid-dependent adolescents during behavioral-pharmacological treatment. Journal of Addiction Medicine 2011;5(4):264-71.
17. Moore SK, GuarinoH, Marsch. L. A. This is not who I want to be:" experiences of opioid-dependent youth before, and during, combined buprenorphine and behavioral treatment. Substance Use & Misuse 2014;49(3):303-14.
18. Mullen L, Keenan E, Barry J, Long J, Mulholland D, Grogan L, et al.Factors predicting completion in a cohort of opiate users entering a detoxification programme. Irish Journal of Medical Science 2010;179(4):569-73.
19. Polsky D, Glick HA, Yang J, Subramaniam GA, Poole SA, Woody GE. Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial. Addiction 2010;105(9):1616-24.
20. Subramaniam GA, Warden D, Minhajuddin A, Fishman MJ, Stitzer ML, Adinoff B, et al.Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. Journal of the American Academy of Child and Adolescent Psychiatry 2011;50(11):1120-8.
21. Warden D, Subramaniam GA, Carmody T, Woody GE, Minhajuddin A, Poole SA, et al.Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth. Adaptive Behavior 2012;37(9):1046-53.
22. Wilcox CE, Bogenschutz MP, Nakazawa M, Woody G. Concordance between self-report and urine drug screen data in adolescent opioid. Adaptive Behavior 2013;38(10):2568-74.
23. March L, Moore SK, Solhkhah R, Badger GJ. Predictors of outcome in Buprenorphine treatment for opioid-dependent youth. Proceedings of the 71th Annual Scientific Meeting of the College on Problems of Drug Dependence; 2009 June 20-25; Reno/Sparks, Nevada, USA. 2009.
24. Marsch LA, MooreS, Solhkhah R. A randomized, controlled trial of buprenorphine dosing regimens for opioid dependent youth. Proceedings of the 73rd Annual Scientific Meeting of the College on Problems of Drug Dependence; 2011 June 18-23, Hollywood, Florida. 2011.
25. Australian Institute of Health and Welfare (AIHW). Drugs in Australia 2010: tobacco, alcohol and other drugs. Drug statistics series no. 27. Cat. no. PHE 154. Canberra 2011.
26. Altobelli E, Rapacchietta L, Tiberti S, Petrocelli R, Cicioni L, di Orio F, et al.Association between drug, alcohol and tobacco use in adolescents and socio-familiar factors [Associazione tra l'uso di sostanze stupefacenti, alcol e tabacco negli adolescenti e contesto socio-familiare]. Annali d'Igiene 2005;17:57-65.
27. Amato L, Minozzi S, Davoli M, Vecchi S, Ferri M, Mayet S. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database of Systematic Reviews 2011, Issue 9. [DOI:].
28. Amato L, Davoli M, Minozzi S, Ferroni E, Ali R, Ferri M. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI:].
29. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration.. Available from www.cochrane-handbook.org 2008.
30. Day E, Ison J, Strang J. Inpatient versus other settings for detoxification for opioid dependence. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI:].
31. European Monitoring Centre for Drugd & Drug Addiction (EMCDDA). Annual Report: The state of the drugs problem in Europe. European Union and Norway. Ofce for publications of the European Communities, Luxembourg 2012.
32. Hibell B, Guttormsson U, Ahlström S, Balakireva O, Bjarnason T, Kokkevi A, et al.The 2011 ESPAD report: substance use among students in 36 European countries. Swedish Council for Information on Alcohol and Other Drugs, Stockholm, Sweden 2012.
33. Gossop M, Green L, Phillips G, Bradley B. Lapse, relapse and survival among opiate addicts after treatment. British Journal of Psychiatry 1989;154:348-53.
34. Gowing L, Ali R, White J. Buprenorphine for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI:].
35. Gowing L, Ali R, White J. Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI:].
36. Gowing L, Ali R, White J. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI:].
37. Gowing L, Farrell M, Ali R, White J. Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2014, Issue 3. [DOI:].
38. Hunt RD, Capper L, O'Connel P. Clonidine in child and adolescent psychiatry. Journal of Child Adolescent Psychofarmacology 1990;1:87-102.
39. Kaminer Y. Pharmacotherapy for adolescents with psychoactive substance use disorders. NIDA Research Monograph 1995;156:291-324.
40. Kleber HD, Riordan CE. The treatment of narcotic withdrawal: a historical review. Journal of Clinical Psichiatry 1982;43(6):30-4.
41. Levy S, Vaughan BL, Angulo M, Knight JR. Buprenorphine replacement therapy for adolescents with opioid dependence: early experience from a children's hospital-based outpatient treatment program. Journal of Adolescent Health 2007;40(5):477-82.
42. Lipton DS, Maranda MJ. Detoxification from heroin dependency: an overview of method and effectiveness. Advances in Alcohol and Substance Abuse 1983;2(1):31-55.
43. Mattick RP, Hall W. Are detoxification programmes effective?. Lancet 1996;347:97-100.
44. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national results on drug use: 2012 Overview, Key Findings on Adolescent Drug Use. Ann Arbor: Institute for Social Research, The University of Michigan. 2013 2013.
45. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-46, HHS 2013;Publication No. (SMA) 13-4795. Rockville 2013.
46. Smith B, Fagan J, Kernan K. Outcomes of heroin dependent adolescents presenting for opiate substitution treatment. Journal of Substance Abuse Treatment 2012;42(1):35-44.
47. Vaillant GE. What can long-term follow-up teach us about relapse and prevention of relapse in addiction?. British Journal of Addiction 1988;83(10):1147-57.
48. Minozzi S, Amato L, Davoli M. Detoxification treatments for opiate dependent adolescents. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI:].